Development of ITI-333, a ?-opioid receptor partial agonist and 5HT2A and D1 receptor antagonist, for the treatment of opioid use disorders
Ended Cooperative Agreement Awarded Last action
- Award ID
- UG3DA047699
- Recipient
-
Intra-Cellular Therapies, Inc. UEI VA5JXLCJHDK7
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $12,000,352
Award facts
- Assistance listing
- 93.279 Drug Use and Addiction Research Programs
- Completion date
- Originally
- Funding
-
- $9,083,278.00 Federal
- $2,917,074.00 Non-federal
- Place of performance
- New York, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $2,917,074 | $0 | |
| Amendment | $2,917,074 | $2,917,074 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Original award | $3,249,130 | $0 |
Show all 27
Quick answers
Who received award UG3DA047699?
UG3DA047699 was awarded to Intra-Cellular Therapies, Inc. by National Institute on Drug Abuse (National Institutes of Health) on January 1, 2019.
How much is award UG3DA047699 worth?
$12,000,352 has been obligated on UG3DA047699: $9,083,278 in federal funding and $2,917,074 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award